(Q44198669)

30 November 2017

title

Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines (English)

1 reference

30 November 2017

1 reference

Wakasugi H

1

1 reference

30 November 2017

Dokhelar MC

2

1 reference

30 November 2017

Garson D

3

1 reference

30 November 2017

Harel-Bellan A

4

1 reference

30 November 2017

Fradelizi D

5

1 reference

30 November 2017

Tursz T

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 March 1985

1 reference

European Journal of Immunology

30 November 2017

published in

1 reference

30 November 2017

volume

15

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

256-261

1 reference

The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Leukemia cell lines can replace monocytes for mitogen-induced T-lymphocyte responses: this accessory function is dependent upon their differentiation stage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Stable variants affecting B cell alloantigens in human lymphoid cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

A minimum of four human class II α-chain genes are encoded in the HLA region of chromosome 6

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Quantitation of Human Thymus-Leukemia-Associated Antigen in Established Hematopoietic Cell Lines by Radioimmunoassay2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Monoclonal antibodies that bind to the human erythrocyte-membrane glycoproteins glycophorin A and Band 3 [proceedings]

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Expression of a 26,000-dalton glycoprotein on activated human T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Monoclonal antibodies against human granulocytes and myeloid differentiation antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Monoclonal antibody against a Burkitt lymphoma-associated antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Interleukin 1 is more than an interleukin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

HLA-D Region Molecules Restrict Proliferative T Cell Responses to Antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830150309

7 January 2021

Identifiers

DOI

10.1002/EJI.1830150309

1 reference

30 November 2017

1 reference